Back to search

Ireland· IE-PA-EU/1/24/1898/001

Lyvdelzi 10 mg hard capsules

A seladelpar product containing seladelpar lysine dihydrate, registered in Ireland by Cymabay Ireland Limited. The same ATC class is registered in 11 of our 19 countries.

ATC A05AX07

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedLyvdelzi 10 mg hard capsulesATCA05AX07REGISTER NO.IE-PA-EU/1/24/1898/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Seladelpar is registered in 11 of 19 countries.

Countries holding a registration under ATC A05AX07 (seladelpar), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 7 of them publish a price we can compare per daily dose

Seladelpar · ATC A05AX07

11 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Seladelpar lysine dihydrate
Manufacturer
Cymabay Ireland Limited
Country
Ireland (IE)
ATC code
A05AX07
ATC class
Seladelpar
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    EU/1/24/1898/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/800e7a81-6bed-4d8d-bbfb-b824bd079b56
GET /v1/drugs/800e7a81-6bed-4d8d-bbfb-b824bd079b56?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "A05AX07"
  ],
  "strength": null,
  "pa_number": "EU/1/24/1898/001",
  "substances": [
    "Seladelpar lysine dihydrate"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "20/02/2025",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about seladelpar.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.